Madrone Advisors, LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Madrone Advisors, LLC reported 6 stock positions worth $569.5 million. Its top holding was Stoneco Class A (STNE) at 53.3% of the portfolio, followed by Vanguard Tot World STK ETF (VT, 39.2%) and Pacific Biosciences of Calif (PACB, 5.6%). Compared with Q1 2024, it sold out of 1, added to 1 and reduced 2. The biggest buy was Pacific Biosciences of Calif (PACB, shares +33%) and the biggest sale an exit from Cue Health (HLTHQ).
- Most Recent 13F
- Q2 2026
- Location
- Denver, CO
- CIK
- 0001964563
- Portfolio Value
- $569.5M (Q2 2024)
- SEC Filing
- 0001104659-24-089645 ↗ filed Aug 14, 2024
Holdings Value
Holdings 6 stocks · $569.5M
| STNE Stoneco Ltd. Class A | 53.34% | 25,339,276 | $303.8M | No change |
| VT Vanguard Tot World STK ETF | 39.21% | 1,982,655 | $223.3M | Reduce -4.4% |
| PACB Pacific Biosciences of Calif | 5.63% | 23,391,915 | $32.0M | Add +33.0% |
| ILMN Illumina Inc. | 1.47% | 80,000 | $8.4M | No change |
| OPRT Oportun Financial Corp. | 0.32% | 623,295 | $1.8M | No change |
| GRAL Grail Inc. | 0.04% | 13,333 | $205K | Reduce -0.2% |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
| PACB Pacific Biosciences of Calif | Add +33.0% | 5.63% | −3.41 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 6 | $1.4B | STUB, STNE, QXO, VT, COF |
| Q1 2026 | 5 | $1.0B | STUB, STNE, VT, QXO, FIG |
| Q4 2025 | 5 | $1.6B | STUB, STNE, QXO, VT, FIG |
| Q3 2025 | 6 | $2.0B | STUB, STNE, QXO, VT, FIG |
| Q2 2025 | 5 | $719.6M | STNE, QXO, VT, PACB, OPRT |
| Q1 2025 | 6 | $597.0M | STNE, QXO, VT, PACB, ILMN |
| Q4 2024 | 6 | $524.8M | STNE, QXO, VT, PACB, ILMN |
| Q3 2024 | 6 | $626.2M | STNE, QXO, VT, PACB, ILMN |
| Q2 2024 | 6 | $569.5M | STNE, VT, PACB, ILMN, OPRT |
| Q1 2024 | 6 | $729.9M | STNE, VT, PACB, ILMN, OPRT |